drugset / Trial / NCT02411773

Sympatholysis in Chronic Kidney Disease

NCT02411773

Phase 1 Recruiting 110 enrolled Emory University
RandomizedFactorialOpen-labelBasic science

Summary

The purpose of this study is to find out why patients with chronic kidney disease (CKD) have poor exercise capacity and what causes an increase in blood pressure during exercise (i.e. increased adrenaline levels, or decreased ability of blood vessels to dilate).

Timeline

Start
2015-06-11
Primary completion
2027-06
Completion
2027-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator sodium bicarbonate Diagnostic / imaging agent 1300 mg Oral
Comparator sodium bicarbonate Diagnostic / imaging agent 2600 mg Oral